Active, Not Recruiting
A Study of SH3765 Tablets in Combination With Fulvestrant in Patients With HR+/HER2- Advanced Breast Cancer.
NCT07557004
- Conditions
- HR+ / HER2- Advanced Breast Cancer
- Locations
-
- The First Affiliated Hospital Of USTC Anhui Provincial Hospital Hefei, Anhui, China